Impilo is a Nordic investment company founded in 2016, focusing on investments in companies within the pharmaceutical, medtech, specialist pharma services, and healthcare-related services industries. Their investment strategy emphasizes positive and sustainable development in the societies and markets where they operate. They are keen on investing in companies that contribute to better health outcomes and sustainable healthcare. Impilo aims to improve the quality of care, increase accessibility, lower healthcare costs, and prevent the need for care through their investments. Their portfolio targets companies with enterprise values of EUR 50m-200m, focusing on private majority investments. Commitment to sustainable healthcare solutions and driving positive change defines their goals and philosophy.
Deal activity and portfolio updates would appear here
Connect your data source to see recent transactions